Compare AJANTA PHARMA with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA SHASUN PHARMA AJANTA PHARMA/
SHASUN PHARMA
 
P/E (TTM) x 24.6 123.9 19.9% View Chart
P/BV x 6.8 8.5 80.2% View Chart
Dividend Yield % 0.5 0.2 220.9%  

Financials

 AJANTA PHARMA   SHASUN PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
SHASUN PHARMA
Mar-14
AJANTA PHARMA/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,42294 1,509.4%   
Low Rs89846 1,968.4%   
Sales per share (Unadj.) Rs233.5214.2 109.0%  
Earnings per share (Unadj.) Rs44.05.3 823.9%  
Cash flow per share (Unadj.) Rs52.215.8 329.7%  
Dividends per share (Unadj.) Rs9.001.00 900.0%  
Dividend yield (eoy) %0.81.4 54.2%  
Book value per share (Unadj.) Rs255.153.3 478.2%  
Shares outstanding (eoy) m88.0256.62 155.5%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.00.3 1,521.8%   
Avg P/E ratio x26.413.1 201.4%  
P/CF ratio (eoy) x22.24.4 503.3%  
Price / Book Value ratio x4.51.3 347.0%  
Dividend payout %20.518.7 109.2%   
Avg Mkt Cap Rs m102,0813,958 2,579.3%   
No. of employees `0006.8NA-   
Total wages/salary Rs m4,3072,164 199.1%   
Avg. sales/employee Rs Th3,022.6NM-  
Avg. wages/employee Rs Th633.4NM-  
Avg. net profit/employee Rs Th569.1NM-  
INCOME DATA
Net Sales Rs m20,55412,127 169.5%  
Other income Rs m211229 91.9%   
Total revenues Rs m20,76512,356 168.0%   
Gross profit Rs m5,6641,009 561.3%  
Depreciation Rs m721594 121.4%   
Interest Rs m12415 2.8%   
Profit before tax Rs m5,143230 2,238.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273-73 -1,750.6%   
Profit after tax Rs m3,870302 1,280.8%  
Gross profit margin %27.68.3 331.2%  
Effective tax rate %24.8-31.7 -78.2%   
Net profit margin %18.82.5 755.7%  
BALANCE SHEET DATA
Current assets Rs m11,8126,884 171.6%   
Current liabilities Rs m3,7768,456 44.7%   
Net working cap to sales %39.1-13.0 -301.7%  
Current ratio x3.10.8 384.2%  
Inventory Days Days7762 125.6%  
Debtors Days Days82108 75.9%  
Net fixed assets Rs m14,3984,970 289.7%   
Share capital Rs m175113 154.8%   
"Free" reserves Rs m22,2772,875 774.9%   
Net worth Rs m22,4523,020 743.4%   
Long term debt Rs m71,817 0.4%   
Total assets Rs m26,96213,347 202.0%  
Interest coverage x444.31.6 28,604.8%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.9 83.9%   
Return on assets %14.45.4 267.9%  
Return on equity %17.210.0 172.3%  
Return on capital %23.013.3 172.3%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m10,6825,843 182.8%   
Fx outflow Rs m2,1022,173 96.7%   
Net fx Rs m8,5803,669 233.8%   
CASH FLOW
From Operations Rs m3,748398 942.6%  
From Investments Rs m-2,228-1,635 136.3%  
From Financial Activity Rs m-1,4751,309 -112.7%  
Net Cashflow Rs m4571 63.5%  

Share Holding

Indian Promoters % 73.8 39.2 188.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 3.6 43.1%  
FIIs % 7.6 17.6 43.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 39.6 42.9%  
Shareholders   20,968 20,750 101.1%  
Pledged promoter(s) holding % 4.4 12.3 35.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  DR. DATSONS LABS  

Compare AJANTA PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Nosedived 1,939 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended deep in the red.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Feb 26, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - SUVEN LIFE SCIENCES COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS